SX
60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
$0.96 -3.41% (-$0.03)
1M -15.40%
Market Cap $800.6K
P/E Ratio -
Div. Yield -
ROE 212.78%
Bulios Fair Price
$1.01
5.6% upside
Current Price
$0.96
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SXTP is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.72x
P/B 0.32x
P/E N/A
Growth
100 /100
Growing Rev. growth 65.15%
EPS growth N/A
FCF growth N/A
Profitability
6 /100
Weak Gross margin 19.42%
Net margin 730.23%
Op. margin 774.90%
Quality
3 /100
Poor ROIC 352.37%
ROE 212.78%
ROA 189.43%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 2.32x
Int. coverage -1,069.34x
Stability
1 /100
Unstable Beta 2.54x
Rev. volatility 63.33%
EPS volatility 1,097.77%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SXTP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Geoffrey Stuart Dow
Employees
3
Headquarters
Washington
Upcoming events
12 NOV
Earnings
Upcoming earnings report